Management ChangeJun 15, 2026, 04:12 PM
PURE Bioscience CEO Robert Bartlett to Retire; Jeff Kitchell Appointed
AI Summary
PURE Bioscience announced that CEO Robert Bartlett will retire on July 31, 2026, with President Jeff Kitchell appointed as the new CEO effective August 1, 2026. Additionally, board member Bernard Blotner will step down. The company reported fiscal third-quarter net product sales of $506,000, a 3.5% increase year-over-year, alongside a net loss of $624,000. For the nine months, net product sales grew 15.4% to $1,656,000, and net loss improved to $1,873,000.
Key Highlights
- CEO Robert Bartlett will retire on July 31, 2026, remaining as a Board Member and Advisor.
- President Jeff Kitchell has been appointed as the new CEO, effective August 1, 2026, and will join the Board.
- Board member Bernard Blotner will be leaving PURE's Board of Directors.
- Fiscal Q3 2026 net product sales increased 3.5% to $506,000 from $489,000 year-over-year.
- Fiscal Q3 2026 net loss was $624,000, compared to $580,000 in the prior year quarter.
- Nine-month net product sales grew 15.4% to $1,656,000 from $1,435,000 year-over-year.
- Nine-month net loss improved to $1,873,000 from $2,067,000 in the prior year period.
- Company launched PURE® Clean and expanded into new industries like dairy and transportation.
Price Impact
More from PURE